This compound is primarily used in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring both bromo and fluoro substituents, makes it a valuable building block for designing drug candidates, particularly in the fields of oncology and neurology. It is often employed in the creation of small molecule inhibitors targeting specific enzymes or receptors involved in disease pathways. Additionally, its aldehyde group allows for further functionalization, enabling chemists to develop diverse chemical libraries for high-throughput screening. This compound is also utilized in the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of potential therapeutic agents.